Evelina Tacconelli

Evelina Tacconelli's AcademicInfluence.com Rankings

Evelina Tacconelli

Philosophy

#5760

World Rank

#8653

Historical Rank

Logic

#2979

World Rank

#4067

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Evelina Tacconelli's Degrees

PhD Public Health University of Oxford

Why Is Evelina Tacconelli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Evelina Tacconelli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Systematic reviews: CRD's guidance for undertaking reviews in health care (2010) (2717)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2017) (2610)
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. (2014) (646)
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. (2010) (564)
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. (2018) (563)
Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. (2017) (470)
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. (2007) (419)
Combination therapy for carbapenem-resistant Gram-negative bacteria. (2014) (225)
In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. (1999) (217)
Monitoring approaches for health-care workers during the COVID-19 pandemic (2020) (199)
Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. (2006) (188)
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. (2012) (185)
Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. (2003) (182)
Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control (2017) (178)
Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. (2007) (176)
Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. (2006) (175)
Surveillance for control of antimicrobial resistance. (2017) (166)
Critical analysis of antibacterial agents in clinical development (2020) (147)
Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. (1999) (146)
Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. (2004) (141)
Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. (2009) (140)
Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. (2009) (138)
Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings (2009) (137)
Vancomycin-resistant enterococci (VRE): transmission and control. (2008) (136)
Antibiotic Usage and Risk of Colonization and Infection with Antibiotic-Resistant Bacteria: a Hospital Population-Based Study (2009) (131)
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study (2016) (131)
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae (2016) (127)
European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM –European Society of intensive care Medicine) (2021) (124)
Prosthetic joint infection: recent developments in diagnosis and management. (2010) (116)
Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia (2020) (112)
Public health burden of antimicrobial resistance in Europe. (2019) (104)
The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. (1995) (101)
Multidrug-Resistant Pseudomonas Aeruginosa Bloodstream Infections: Analysis of Trends in Prevalence and Epidemiology (2002) (98)
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. (2014) (96)
Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. (2014) (91)
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance. (2016) (91)
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. (1998) (89)
Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. (2016) (87)
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (2020) (87)
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. (2019) (85)
Deciphering the state of immune silence in fatal COVID-19 patients (2020) (83)
Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. (2002) (81)
Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. (2016) (78)
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. (2002) (77)
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy (2004) (77)
Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. (2003) (76)
Prediction of bacteremia using TREAT, a computerized decision-support system. (2006) (76)
Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. (2018) (73)
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario (2003) (68)
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli (2012) (68)
The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. (2013) (67)
Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule. (2004) (66)
Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans. (2017) (65)
Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. (2012) (65)
Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries. (2015) (64)
Central venous catheter-related sepsis in a cohort of 366 hospitalised patients (1997) (64)
STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship (2016) (64)
Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase-Producing Escherichia coli: A Point/Counterpoint Review. (2017) (63)
Risk factors and prognostic indicators of bacterial meningitis in a cohort of 3580 postneurosurgical patients. (2001) (63)
Relative tachycardia in patients with sepsis: an independent risk factor for mortality. (2007) (63)
The TREAT project: decision support and prediction using causal probabilistic networks. (2007) (62)
Influx of Multidrug-Resistant, Gram-Negative Bacteria in the Hospital Setting and the Role of Elderly Patients With Bacterial Bloodstream Infection (2009) (62)
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. (1996) (61)
Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. (2001) (59)
Increased mortality among elderly patients with meticillin-resistant Staphylococcus aureus bacteraemia. (2006) (59)
Corrigendum to “The global threat of antimicrobial resistance: science for intervention” [New Microbes New Infect 6 (2015): 22–29] (2015) (58)
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. (2008) (57)
Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? (2014) (56)
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis (2020) (55)
Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. (1997) (54)
The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis (2007) (51)
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance (2021) (51)
Screening and isolation for infection control. (2009) (50)
Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. (2009) (49)
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort (2017) (49)
Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study (2022) (47)
MRSA infections among patients in the emergency department: a European multicentre study (2017) (46)
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. (2008) (45)
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study. (2016) (45)
Candidemia in HIV-Infected Subjects (1999) (44)
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage (2020) (43)
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae (2018) (41)
Optimising design of research to evaluate antibiotic stewardship interventions; consensus recommendations of a multinational working group. (2020) (41)
Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. (2011) (41)
Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay. (1998) (37)
The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information. (2017) (37)
HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. (2000) (37)
BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection (2018) (36)
Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management (2009) (36)
Agreement among Healthcare Professionals in Ten European Countries in Diagnosing Case-Vignettes of Surgical-Site Infections (2013) (35)
Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey. (2017) (35)
New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. (2006) (34)
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma (2010) (34)
Central venous catheters and bloodstream infection. (2000) (34)
Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone. (2014) (34)
Osteoarticular bacterial infections are rare in HIV-infected patients. 14 cases found among 4,023 HIV-infected patients. (1997) (34)
Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects. (2000) (34)
Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility. (2004) (33)
A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine (2020) (33)
Clinical Course and Long-Term Outcome of Hantavirus-Associated Nephropathia Epidemica, Germany (2015) (33)
Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. (1995) (33)
Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system. (2007) (32)
Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. (2018) (32)
Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica. (2015) (31)
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae (2017) (30)
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome. (2001) (28)
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. (2021) (28)
Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors? (2019) (28)
Pneumothorax in HIV-infected patients: role of Pneumocystis carinii pneumonia and pulmonary tuberculosis. (1997) (27)
Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission. (2003) (27)
HIV‐Associated Bacteremia: How It Has Changed in the Highly Active Antiretroviral Therapy (HAART) Era (2000) (27)
Hospital-Acquired Candidemia in HIV-Infected Patients. Incidence, Risk Factors and Predictors of Outcome (2004) (27)
Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infection. (2000) (26)
Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1) (2019) (24)
Impact of Highly Active Antiretroviral Therapy (HAART) on the Incidence of Bacterial Infections in HIV-Infected Subjects (2003) (24)
Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis (2020) (23)
Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study. (2019) (23)
Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection. (1997) (23)
Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & Discovery of new antibiotics in European countries. (2019) (23)
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy. (1999) (22)
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic (2020) (22)
Management of obstetrics and gynaecological patients with COVID-19 (2020) (22)
Fluconazole resistant oral candidiasis in HIV-infected patients. (1997) (22)
Estimating the association between antibiotic exposure and colonisation with ESBL-producing Gram negative bacteria: a multicentre, prospective cohort study. (2019) (21)
Multicentre study of antimicrobial resistance and antibiotic consumption among 6,780 patients with bloodstream infections (2006) (21)
Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone (2017) (21)
The Importance of Addressing Multidrug Resistance and Not Assuming Single-Drug Resistance in Case-Control Studies (2006) (21)
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic (2021) (21)
Staphylococcus aureus infections. (1998) (21)
Corynebacterium striatum bacteremia in a patient with AIDS. (1994) (20)
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients. (2019) (20)
Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importance. (1997) (20)
Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals. (1998) (20)
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis (2022) (20)
Predictors of Staphylococcus aureus pneumonia associated with human immunodeficiency virus infection. (1996) (20)
Participation of Elderly Adults in Randomized Controlled Trials Addressing Antibiotic Treatment of Pneumonia (2015) (20)
Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case (2020) (19)
Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. (2000) (19)
Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe (2019) (18)
Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile (2021) (18)
Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals. (2020) (17)
National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the Netherlands. (2011) (17)
MRSA decolonization failure—are biofilms the missing link? (2017) (17)
Changes in Incidence and Risk Factors of Mycobacterium avium Complex Infections in Patients with AIDS in the Era of New Antiretroviral Therapies (2001) (17)
Social media posts and online search behaviour as early-warning system for MRSA outbreaks (2018) (16)
Outbreak of Saprochaete clavata Sepsis in Hematology Patients: Combined Use of MALDI-TOF and Sequencing Strategy to Identify and Correlate the Episodes (2020) (16)
Rapid onset of bronchiectasis in COVID-19 Pneumonia: two cases studied with CT (2020) (16)
Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS. (1996) (15)
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg (2020) (15)
Azole Susceptibility Patterns and Genetic Relationship Among Oral Candida Strains Isolated in the Era of Highly Active Antiretroviral Therapy (2002) (15)
Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study. (2020) (15)
Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance (2020) (15)
A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements (2016) (15)
Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list. (2019) (15)
Is there still a role for vancomycin in skin and soft-tissue infections? (2017) (14)
When did the doctors become fomites? (2011) (14)
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. (2017) (14)
Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections. (2019) (14)
[Infectious diseases as a clinical specialty in Germany and Europe]. (2015) (14)
Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology. (2020) (13)
Fighting the enemy within (2017) (13)
Personal life and working conditions of trainees and young specialists in clinical microbiology and infectious diseases in Europe: a questionnaire survey (2017) (13)
Vitamin D and disease severity in coronavirus disease 19 (COVID-19). (2021) (13)
A one health framework to estimate the cost of antimicrobial resistance (2020) (13)
Nervous system: subclinical target of SARS-CoV-2 infection (2020) (12)
Diagnostic accuracy of point-of-care tests in acute community acquired-lower respiratory tract infections. A systematic review and meta-analysis. (2021) (12)
Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010. (2011) (12)
Science without meritocracy. Discrimination among European specialists in infectious diseases and clinical microbiology: a questionnaire survey (2012) (12)
EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol (2017) (12)
Case report: Retinopathy after malaria prophylaxis with chloroquine. (2001) (12)
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis (2021) (12)
Clostridium difficile-associated diarrhea in human immunodeficiency virus infection--a changing scenario. (1999) (12)
Antimicrobial therapy of Staphylococcus aureus bloodstream infection (2007) (12)
Pemphigus vulgaris in a human-immunodeficiency-virus-infected patient. (1998) (11)
Infection Risk in Sterile Operative Procedures. (2016) (11)
Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae (2018) (11)
Translational research strategy: an essential approach to fight the spread of antimicrobial resistance. (2014) (11)
SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers (2022) (11)
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. (2021) (11)
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies (2021) (11)
The Daschner Guide to In-Hospital Antibiotic Therapy 2012 – 2013. (2009) (10)
ESCMID-an international Europe-based society committed to fostering cross-border collaboration and education to improve patient care. (2018) (10)
P-170 glycoprotein (P-170) is involved in the impairment of natural killer cell-mediated cytotoxicity in HIV+ patients. (1995) (10)
Use of evidence-based recommendations in an antibiotic care bundle for the intensive care unit. (2018) (10)
Risk scoring and bloodstream infections. (2007) (10)
Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study (2012) (10)
Education and training programmes for infection prevention and control professionals: mapping the current opportunities and local needs in European countries (2020) (10)
Role of new antibiotics for KPC-producing Klebsiella pneumoniae. (2021) (10)
Whole-Genome Sequencing (WGS) of Carbapenem-Resistant K. pneumoniae Isolated in Long-Term Care Facilities in the Northern Italian Region (2021) (10)
Candidiasis and HIV-Protease Inhibitors: The Expected and the Unexpected (2004) (10)
PRAISE: providing a roadmap for automated infection surveillance in Europe. (2021) (10)
CD16+CD56+CD8+ natural killer (NK) cells are decreased during HIV infection. (1997) (9)
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 (2021) (9)
SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people (2021) (9)
Antibiotic Stewardship 2.0 (2017) (9)
A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency (2021) (9)
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group (2021) (9)
Role of trimethoprim‐sulphamethoxazole in preventing HIV‐associated bacteraemia (1997) (9)
A framework to develop semiautomated surveillance of surgical site infections: An international multicenter study (2019) (9)
Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: a multicentre study promoted by the Italian Society of Infectious and Tropical Diseases. (2019) (9)
Impact of availability of guidelines and active surveillance in reducing the incidence of ventilator-associated pneumonia in Europe and worldwide (2014) (9)
[Central venous catheter-related sepsis: one year experience in a large university hospital] (1999) (8)
Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2) (2019) (8)
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (8)
How could we reduce antibiotic use in critically ill patients? (2011) (8)
Assessment of COVID-19 progression on day 5 from symptoms onset (2021) (8)
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. (2017) (8)
Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals (2018) (8)
The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population (2021) (8)
Recurrent venous thrombosis in a patient with haemophilia A and HIV infection. (2002) (8)
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria (2021) (8)
Infection prevention and control in Europe - the picture in the mosaic. (2015) (8)
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (8)
Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (7)
Secondary Pneumocystis carinii pneumonia prophylaxis with trimethoprim-sulphamethoxazole does not prevent bacterial pneumonia in HIV-infected persons. (1996) (7)
White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (7)
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern (2022) (7)
Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. (2017) (7)
Impact of implementing a non-restrictive antibiotic stewardship program in an emergency department: a four-year quasi-experimental prospective study (2020) (7)
Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response (2022) (7)
Age as a prognostic factor in AIDS (1996) (7)
Correlation Between Cidofovir-Associated Uveitis and Failing Immunorestoration During HAART (2003) (7)
Correction: Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure (2015) (7)
Household acquisition and transmission of ESBL-producing Enterobacteriaceae after hospital discharge of ESBL-positive index patients. (2021) (7)
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project (2020) (7)
Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project (2020) (7)
High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals (2018) (7)
Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (7)
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (6)
Vancomycin Way of Administration: Where is the Evidence? (2011) (6)
Does gender affect the outcome of community-acquired Staphylococcus aureus bacteraemia? (2017) (6)
Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries (2022) (6)
The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysis. (2020) (6)
Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region (2022) (6)
Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review (2017) (6)
Risk factors, nutritional status, and quality of life in HIV-infected patients with enteric salmonellosis. (1998) (6)
Methicillin-resistant Staphylococcus aureus (MRSA) (2010) (6)
Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use (2017) (6)
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) (2022) (6)
Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol (2020) (6)
Pitfalls of Computed Tomography in the Coronavirus 2019 (COVID-19) Era: A New Perspective on Ground-Glass Opacities (2020) (6)
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (6)
In vitro susceptibility to 19 agents other than &bgr;-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission (2017) (5)
What is the evidence base of used aggregated antibiotic resistance percentages to change empiric antibiotic treatment? A scoping review (2021) (5)
Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy (2022) (5)
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort (2022) (5)
White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (5)
ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting (2022) (5)
Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and food items: A multicentre European study. (2021) (5)
The WHO Essential Medicines list AWaRe book: from a list to a quality improvement system. (2022) (5)
Inequality dynamics in the workplace among microbiologists and infectious disease specialists: a qualitative study in five European countries. (2017) (5)
Tuberculosis significantly reduces the survival of patients with AIDS. (1997) (5)
Fighting antibiotic resistance all over Europe (2010) (5)
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment (2022) (4)
Meticillin-resistant (MRSA): screening and decolonisation (2011) (4)
Vancomycin-resistente Enterokokken: Welche Therapieoptionen gibt es? (2015) (4)
Identifying risk factors for infections: the role of meta-analyses. (2009) (4)
Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list-authors' response. (2020) (4)
Drug resistant Pseudomonas aeruginosa bacteremia in HIV-infected patients. (1995) (4)
TREAT: a system for balancing antibiotic treatment against development of drug resistance (2004) (4)
Meningoencephalomyelitis caused by herpes simplex virus‐1 in a patient with idiopathic T CD4+ lymphocytopenia (1998) (4)
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study (2022) (3)
Governance aspects of large-scale implementation of automated surveillance of healthcare-associated infections. (2021) (3)
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence (2022) (3)
[Erratum to: Antibiotic Stewardship 2.0 : Individualization of therapy]. (2017) (3)
New antibiotics for skin and skin-structure infections. (2014) (3)
Does Online Search Behavior Coincide with Candida auris Cases? An Exploratory Study (2019) (3)
Beyond COVID-19—a paradigm shift in infection management? (2020) (3)
Harmonization and standardization of data for a pan-European cohort on SARS- CoV-2 pandemic (2022) (3)
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study (2022) (3)
High prevalence of Pseudomonas aeruginosa carriage in residents of French and German long-term care facilities. (2022) (3)
Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study. (2022) (3)
Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study (2020) (3)
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals , 2010 and 2011 (2016) (2)
The management of methicillin-resistant Staphylococcus aureus infection in Europe. (2010) (2)
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments (2022) (2)
Treatment of the Most Frequent Types of Bacterial Endocarditis (2012) (2)
Omicron Neutralizing and Anti-SARS-CoV-2 S-RBD Antibodies in Naïve and Convalescent Populations After Homologous and Heterologous Boosting With an mRNA Vaccine (2022) (2)
In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol (2020) (2)
People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission (2022) (2)
A computerized decision support system (TREAT) to reduce inappropriate antibiotic therapy of bacterial infection (2004) (2)
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial (2023) (2)
Control interventions for preventing spread of vancomycin-resistant enterococci (VRE) in hospitals (2008) (2)
Evaluation of the scientific impact of the Ebola epidemic: a systematic review. (2017) (2)
Microbiota-associated risk factors for C. difficile acquisition in hospitalized patients: A prospective, multicentric study. (2020) (2)
Burden of Staphylococcus aureus endocarditis: how real is the threat? (2012) (2)
Predictors of clinical evolution of SARS‐CoV‐2 infection in hematological patients: A systematic review and meta‐analysis (2022) (2)
136 – Principles of Anti-infective Therapy and Surgical Prophylaxis (2017) (2)
The SARS-CoV-2 pandemic puts the spotlight on gender inequality in clinical research (2021) (2)
Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant Klebsiella pneumoniae Complex in Germany (2022) (2)
[Bacterial pneumonia in HIV-infected patients] (1999) (2)
Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp. (2022) (2)
Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study) (2020) (2)
Resolving colistin resistance and heteroresistance in Enterobacter species (2023) (2)
Non-AIDS-defining neoplasms and HIV infection. (1999) (2)
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor (2020) (1)
Missions and Objectives of EUCIC and ESGAP (2017) (1)
P858 Beta-lactam alone compared to β-lactam-macrolide combination therapy for community-acquired pneumonia: prospective, observational study using a propensity score (2007) (1)
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation (2023) (1)
Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors-a cross-sectional study in seven German university hospitals from 2014 to 2018. (2022) (1)
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study (2019) (1)
Gram-negative bacillary meningitis in adults. (1995) (1)
A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies (2020) (1)
1723P Organizational challenges and oncological activity volumes during the SARS-CoV-2 epidemic peak in Verona, Italy (2020) (1)
The Most Common Errors in Antibiotic Therapy (2012) (1)
[Treatment options for serious infections caused by vancomycin-resistant enterococci]. (2015) (1)
Old and New Tools in the Diagnosis of Central Venous Catheter-Related Bloodstream Infections: Is there a Role for Brushing? (2004) (1)
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma (2010) (1)
Multi-Criteria Decision Analysis to Prioritise Hospital Admission of Patients Affected by COVID-19 in Settings with Hospital-Bed Shortage (2020) (1)
Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19–Related Disease (2021) (1)
Aggressive versus conservative initiation of antibiotics. (2013) (1)
Modelling and Simulation of the Effect of Targeted Decolonisation on Incidence of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections in Haematological Patients (2021) (1)
Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial (2022) (1)
The WHO AWaRe Antibiotic Book: providing guidance on optimal use and informing policy. (2022) (1)
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery. (2022) (1)
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study (2022) (1)
Erratum: Amplification of antimicrobial resistance in gut flora of patients treated with ceftriaxone : (Antimicrobial Agents and Chemotherapy (2018) 61: 11 (e00473-17) DOI: 10.1128/AAC.00473-17) (2018) (1)
Fever of Unknown Origin: Differential Diagnosis (2012) (1)
Antibiotic Therapy of the Principal Infections in Children and Adults (2012) (1)
An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales (2020) (1)
Classification of the Antibiotics (2012) (1)
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis (2022) (1)
Association of Patients’ Epidemiological Characteristics and Comorbidities with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of an Umbrella Systematic Review and Meta-Analysis (2022) (1)
Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (1)
Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (1)
Antibiotic Prophylaxis for Enteryx™ Procedure: Preliminary Results (2005) (0)
European survey on the current surveillance practices, management guidelines, treatment pathways, and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI). (2022) (0)
Evaluating BLOOMY and SOFA scores in hospitalised patients - Authors' reply. (2022) (0)
Clinical Impact of Antimicrobial Resistance in Hospitalized Patients: a Systematic Review (2019) (0)
Social media posts and online search behaviour as early-warning system for MRSA outbreaks (2018) (0)
Erratum for Meletiadis et al., “Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone” (2018) (0)
Cardiovascular Diseases Associated Inflammatory Biomarker Levels in a Small Cohort of HIV-1 Infected Patients Deintensificated from Abacavir/Lamivudine/ Dolutegravir to Lamivudine Plus Dolutegravir Running Head: Risk of Cardiovascular Diseases and Abacavir Use (2021) (0)
MRSA decolonization failure—are biofilms the missing link? (2017) (0)
Prediction of bloodstream infections using TREAT: a causal probabilistic network for diagnosis and treatment of infections (2005) (0)
Results from TREAT-WARD observational study (2004) (0)
Quantifying antibiotic impact on within-host dynamics of extended-spectrum beta-lactamase resistance in hospitalized patients (2019) (0)
Risk perception of antimicrobial resistance by infection control specialists in Europe: a case-vignette study (2020) (0)
REPORT : RETINOPATHY AFTER MALARIA PROPHYLAXIS WITH CHLOROQUINE (2001) (0)
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases (2022) (0)
In Reply. (2016) (0)
The Control of MRSA (2012) (0)
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients (2019) (0)
Important Infections and Their Microbiological Diagnosis (2012) (0)
Erratum zu: Antibiotic Stewardship 2.0 (2017) (0)
Effectiveness of antibiotic stewardship interventions in reducing the rate of colonization and infections due to antibiotic resistant bacteria and Clostridium difficile in hospital patients – a systematic review and meta-analysis Study Protocol (2017) (0)
Linking infection control to clinical management of infections to overcome antimicrobial resistance. (2021) (0)
Resistance of Major Clinical Pathogens (2012) (0)
The Caliber of Segmental and Subsegmental Vessels in COVID-19 Pneumonia Is Enlarged: A Distinctive Feature in Comparison with Other Forms of Inflammatory and Thromboembolic Diseases (2020) (0)
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report (2019) (0)
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study (2023) (0)
Diffusion of Antibiotics in Cerebrospinal Fluid and in Cerebral Abscesses (2012) (0)
The antimicrobial resistance travel tool, an interactive evidence-based educational tool to limit antimicrobial resistance spread (2022) (0)
ESCMID white paper: a guide on ESCMID guidance documents. (2019) (0)
Antibiotics in Liver Diseases (2012) (0)
EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach (2022) (0)
P872 BaiCD gene abundance is negatively correlated with Clostridium difficile infection (2018) (0)
Generics and Trade Names (2009) (0)
The severe acute respiratory syndrome coronavirus 2 pandemic puts the spotlight on gender inequality in clinical research (2021) (0)
Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1) (2019) (0)
Comprar The Daschner Guide to In-Hospital Antibiotic Therapy | Frank, Uwe | 9783540483472 | Springer (2009) (0)
Potential for improvement in governance and national action plans to overcome antimicrobial resistance. (2023) (0)
A Lever and a Place to Stand to Predict COVID-19 Progression: Developing a Prognostic Model Based on Day Five from Symptoms Onset (2021) (0)
A one health framework to estimate the cost of antimicrobial resistance (2020) (0)
Antibiotics Marketed in the EU (2012) (0)
Antibiotic Stewardship 2.0 (2017) (0)
The impact of a local antibiotic stewardship program: Low rate of spontaneous bacterial peritonitis and bacteriascites sustained by multidrug-resistant organisms (2021) (0)
Antibiotic Therapy During Pregnancy and Lactation (2012) (0)
A comparison of susceptibility to antibiotics in nosocomial and non-nosocomial infections in Israel, Germany and Italy (2006) (0)
Antibiotics, Antimycotics: Spectrum – Dosage – Adverse Effects – Costs (2012) (0)
Colonisation with Extended-Spectrum Cephalosporin-Resistant Enterobacterales and Infection Risk in Surgical Patients: A Systematic Review and Meta-analysis (2023) (0)
Critical analysis of antibacterial agents in clinical development (2020) (0)
Dalbavancin in the treatment of acute bacterial skin and skin structure and other infections: a safety evaluation (2022) (0)
The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study (2023) (0)
TREAT: an electronic consultant for the clinical microbiologist (2004) (0)
Introduction by Evelina Tacconelli (2017) (0)
Clinical Efficacy of Combination Therapy for the Treatment of Severe Infections Caused by Carbapenem Resistant Gram-Negatives. A Systematic Review of Clinical Studies (2021) (0)
Author response: Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance (2019) (0)
Myocarditis in an HIV-infected patient with Covid-19. (2020) (0)
Failure of Antibiotic Therapy (2012) (0)
Cooperation with Microbiologists (2012) (0)
Beta-lactam alone compared to ß-lactam-macrolide combination therapy for community-acquired pneumonia (2007) (0)
The Most Frequent Pathogens – Choice of Antibiotics (2012) (0)
Accessibility of covariance information creates vulnerability in Federated Learning frameworks (2023) (0)
Hospital antimicrobial stewardship: the way forward - Authors' reply. (2017) (0)
Identifying COVID-19 Progression by Day Five From Symptoms Onset (2021) (0)
Mo1927 - Baicd Gene Abundance is Negatively Correlated with Clostridium Difficile Infection (2018) (0)
Principles of Antibiotic Therapy (2012) (0)
Minimal Duration of Treatment for Bacterial Infections (2012) (0)
Contact precautions for the control of endemic pathogens: Finding the middle path (2023) (0)
Prophylactic Antibiotic Therapy (2012) (0)
A One Health Framework to Estimate Costs of Antimicrobial Resistance (2020) (0)
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis (2021) (0)
Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals (2018) (0)
Comprar The Daschner Guide to In-Hospital Antibiotic Therapy | Tacconelli, Evelina | 9783642184017 | Springer (2011) (0)
Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit (2022) (0)
The clinical and economic impact of surgical site infections after distal pancreatectomy. (2021) (0)
Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2) (2019) (0)
3 Role of scientific societies in guidelines development. The case study of the european society of clinical microbiology and infectious diseases (2019) (0)
New tools for antibiotic stewardship: a lesson for prescribers, researchers, or policy makers? (2022) (0)
Evaluation of a ddPCR Commercial Assay for the Absolute Quantification of the Monkeypox Virus West Africa in Clinical Samples (2023) (0)
Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study. (2022) (0)
The Importance of Addressing Multidrug Resistance and Not Assuming Single-Drug Resistance in Case-Control Studies (2006) (0)
Education and training programmes for infection prevention and control professionals: mapping the current opportunities and local needs in European countries (2020) (0)
Physical Incompatibility of Antibiotics and Antimycotics in Infusion Solutions (2012) (0)
Impact of implementing a non-restrictive antibiotic stewardship program in an emergency department: a four-year quasi-experimental prospective study (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Evelina Tacconelli?

Evelina Tacconelli is affiliated with the following schools:

University of Verona
University of Tübingen